[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Contempo Updates
November 15, 2000

Delirium at the End of LifeCritical Issues in Clinical Practice and Research

Author Affiliations

Author Affiliations: Grey Nun's Community Health Centre and Hospital, Edmonton Regional Palliative Care Program, and the Department of Oncology, Division of Palliative Care Medicine, University of Alberta, Edmonton (Drs Lawlor and Fainsinger); M. D. Anderson Cancer Center and the Department of Symptom Control and Palliative Care, University of Texas, Houston (Dr Bruera).

 

Contempo Updates Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2000;284(19):2427-2429. doi:10.1001/jama.284.19.2427

Delirium frequently complicates care at the end of life. Although usually described as a transient and potentially reversible disorder of cognition and attention,1 paradoxically, delirium often occurs in the last hours or days of life as an irreversible and terminal event.2 Cardinal features of delirium include acute onset with a fluctuating course, the presence of an underlying organic derangement, reduced sensorium, attention deficit, and cognitive or perceptual disturbances.3 Subtypes of delirium are classified according to altered psychomotor activity, and may be hyperactive, hypoactive,1 or mixed.4 In this article, we discuss the epidemiology of delirium at the end of life, as well as its etiology, assessment, psychosocial impact, and treatment strategies and goals.

First Page Preview View Large
First page PDF preview
First page PDF preview
×